Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001553350-25-000044
Filing Date
2025-05-15
Accepted
2025-05-15 16:20:23
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cdio_033125-10q.htm   iXBRL 10-Q 792199
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 8462
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 8159
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 4837
5 EXHIBIT 32.2 ex32x2.htm EX-32.2 4324
  Complete submission text file 0001553350-25-000044.txt   5032533

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdio-20250331.xsd EX-101.SCH 41894
7 XBRL CALCULATION FILE cdio-20250331_cal.xml EX-101.CAL 44830
8 XBRL DEFINITION FILE cdio-20250331_def.xml EX-101.DEF 159551
9 XBRL LABEL FILE cdio-20250331_lab.xml EX-101.LAB 313555
10 XBRL PRESENTATION FILE cdio-20250331_pre.xml EX-101.PRE 274405
71 EXTRACTED XBRL INSTANCE DOCUMENT cdio_033125-10q_htm.xml XML 824931
Mailing Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645
Business Address 311 W. SUPERIOR STREET SUITE 444 CHICAGO IL 60645 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

EIN.: 870925574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41097 | Film No.: 25953651
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)